ICH S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization

E1538043 UNEXPLORED

ICH S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization is an international guideline that outlines nonclinical testing strategies to assess a drug’s potential to cause QT interval prolongation and associated proarrhythmic cardiac risks.

Try in SPARQL Jump to: Surface forms Disambiguation Referenced by

All labels observed (1)

Label	Occurrences
ICH S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization canonical	1

How this entity was disambiguated

This entity first appeared as the object of triple T22458036 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: ICH S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization
Context triple: [ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals, relatedTo, ICH S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization]

A. ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
ICH M3(R2) is an international guideline that harmonizes requirements for nonclinical safety studies needed to support the initiation and progression of human clinical trials and the marketing authorization of pharmaceuticals.
B. ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals is an international guideline that outlines the nonclinical safety testing requirements for biotechnological products such as therapeutic proteins and monoclonal antibodies to support their clinical development and marketing authorization.
C. ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
D. ICH E8 General Considerations for Clinical Trials
ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
E. Map of the Human Heart
Map of the Human Heart is a 1992 romantic drama film that follows the life and love of an Inuit boy who grows up to become a World War II bomber navigator.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: ICH S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization
Target entity description: ICH S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization is an international guideline that outlines nonclinical testing strategies to assess a drug’s potential to cause QT interval prolongation and associated proarrhythmic cardiac risks.

A. ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals
ICH M3(R2) is an international guideline that harmonizes requirements for nonclinical safety studies needed to support the initiation and progression of human clinical trials and the marketing authorization of pharmaceuticals.
B. ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals is an international guideline that outlines the nonclinical safety testing requirements for biotechnological products such as therapeutic proteins and monoclonal antibodies to support their clinical development and marketing authorization.
C. ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals
ICH S9 Nonclinical Evaluation for Anticancer Pharmaceuticals is an international regulatory guideline that outlines the nonclinical safety studies needed to support the development and approval of anticancer drugs in humans.
D. ICH E8 General Considerations for Clinical Trials
ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
E. Map of the Human Heart
Map of the Human Heart is a 1992 romantic drama film that follows the life and love of an Inuit boy who grows up to become a World War II bomber navigator.
F. None of above. chosen

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

ICH M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals → relatedTo → ICH S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization ⓘ

All labels observed (1)

How this entity was disambiguated Show

Referenced by (1)

How this entity was disambiguated